Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : JNJ crawled date : 2021 - 08 - 10 save search
Global Vaccines Markets, 2015-2020, 2020-2025F, 2030F: Anti-Infective, Vaccines Autoimmunity, Cancer, Conjugate, Inactivated and Subunit, Live Attenuated, Recombinant, Toxoid, Monovalent, Multivalent
Published: 2021-08-10 (Crawled : 20:00) - prnewswire.com
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
|
| O: 0.51%
H: 0.13%
C: -0.27%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.28%
H: 0.13%
C: -0.26%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.26%
H: 0.14%
C: -0.69%
autoimmunity cancer vaccine injection infections
Prolacta Bioscience Congratulates Carolyn TenEyck, RN, on Lifetime Achievement Award from National Black Nurses Association
Published: 2021-08-10 (Crawled : 18:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.26%
H: 0.49%
C: 0.29%
bioscience
Pharma Firm Earns $20 Million to Support Presbyopia Treatment Efforts
Published: 2021-08-10 (Crawled : 18:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.26%
H: 0.49%
C: 0.29%
treatment presbyopia pharma
COVID-19 Vaccines Expiring in Wealthy Nations as Developing World Struggles
Published: 2021-08-10 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.26%
H: 0.49%
C: 0.29%
covid vaccine covid-19
Belief Biomed's Gene Therapy for Hemophilia B Receives NMPA IND Approval: First Intravenous Infusion Gene Therapy for Rare Disease in China
Published: 2021-08-10 (Crawled : 16:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.26%
H: 0.49%
C: 0.29%
disease china gene therapy therapy approval gene therapies rare
The Best (and Worst) Mission-driven Organizations in the World
Published: 2021-08-10 (Crawled : 13:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.26%
H: 0.49%
C: 0.29%
MAR | News | $237.36 0.58% 0.57% 1M
|
Consumer Services
|
| O: -0.12%
H: 1.62%
C: 0.76%
Insights on the Patient Monitoring Devices Global Market to 2026 - by Type and Geography
Published: 2021-08-10 (Crawled : 12:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.26%
H: 0.49%
C: 0.29%
GE | News | $150.19 1.44% -0.13% 7M
|
Electronic Technology
|
| O: 0.1%
H: 2.43%
C: 2.19%
BAX | $40.4 2.36% 1.14% 3.3M
|
Health Technology
|
| O: 0.27%
H: 0.16%
C: -0.47%
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: 0.15%
H: 0.17%
C: -0.53%
MASI | $134.395 -0.28% -0.28% 200K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -3.15%
device
Nanox Enters into Acquisition via Merger Agreement with Zebra Medical Vision Ltd. and Announces Entry into Binding Letter of Intent with USARAD Holdings Inc.
Published: 2021-08-10 (Crawled : 12:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.26%
H: 0.49%
C: 0.29%
NNOX | News | $9.02 4.88% 4.44% 990K
|
Health Technology
|
| O: -4.52%
H: 0.83%
C: -9.35%
acquisition merger agreement merge
Visus Therapeutics Secures $20 Million in Additional Financing Led by New Investor LSP, with Participation from Sage Partners
Published: 2021-08-10 (Crawled : 12:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.26%
H: 0.49%
C: 0.29%
Refractive Surgery Devices Market Size Worth $290.8 Million By 2028: Grand View Research, Inc.
Published: 2021-08-10 (Crawled : 09:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.26%
H: 0.49%
C: 0.29%
device research
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.